Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription

Oncotarget

Volumn 5, Issue 21, 2014, Pages 10356-10367

  Ciccarone, Fabio ^a,b   Valentini, Elisabetta ^a,b   Bacalini, Maria Giulia ^c   Zampieri, Michele ^a,b   Calabrese, Roberta ^a,b   Guastafierro, Tiziana ^a,b   Mariano, Germano ^a,b   Reale, Anna ^a,b   Franceschi, Claudio ^c   Caiafa, Paola ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Pasteur Institute   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

5 hydroxymethylcytosine; DNA methylation; Poly(ADP ribosyl)ation; Tet1

Indexed keywords

HISTONE H3; HISTONE H3K4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TET1 PROTEIN; TRANSCRIPTION FACTOR HOXA9; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ADENOSINE DIPHOSPHATE; DNA BINDING PROTEIN; HISTONE; HOMEODOMAIN PROTEIN; ONCOPROTEIN; TET1 PROTEIN, HUMAN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CHROMATIN; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; HISTONE METHYLATION; HOXA9 GENE; HUMAN; HUMAN CELL; TET1 GENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ACUTE LYMPHOBLASTIC LEUKEMIA; BREAST TUMOR; FEMALE; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; JURKAT CELL LINE; MCF 7 CELL LINE; METABOLISM;

ADENOSINE DIPHOSPHATE; BREAST NEOPLASMS; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; JURKAT CELLS; MCF-7 CELLS; POLY(ADP-RIBOSE) POLYMERASES; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84916900267     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1905     Document Type: Article

References (62)

1. Pastor WA, Aravind L, Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol 2013; 14(6):341-356.
2. Shen L, Wu H, Diep D, Yamaguchi S, D'Alessio AC, Fung HL, et al. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 2013; 25;153(3):692-706.
3. Hashimoto H, Hong S, Bhagwat AS, Zhang X, Cheng X. Excision of 5-hydroxymethyluracil and 5-carboxylcytosine by the thymine DNA glycosylase domain: its structural basis and implications for active DNA demethylation. Nucleic Acids Res 2012; 40(20):10203-10214.
4. Branco MR, Ficz G, Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 2011; 13(1):7-13.
5. Shen L, Zhang Y. 5-Hydroxymethylcytosine: generation, fate, and genomic distribution. Curr Opin Cell Biol 2013; 25(3):289-296.
6. Kinney SR, Pradhan S. Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer. Adv Exp Med Biol 2013; 754:57-79.
7. Vincent JJ, Huang Y, Chen PY, Feng S, Calvopina JH, Nee K, et al. Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells. Cell Stem Cell 2013; (124):470-478.
8. Wossidlo M, Nakamura T, Lepikhov K, Marques CJ, Zakhartchenko V, Boiani M, et al. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat Commun 2011; 2:241.
9. Wu H, D'Alessio AC, Ito S, Xia K, Wang Z, Cui K, et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 2011; 473(7347):389-393.
10. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011; 473(7347):398-402.
11. Koh KP, Yabuuchi A, Rao S, Huang Y, CunniffK, Nardone J, et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011; 8(2):200-213.
12. Deplus R, Delatte B, Schwinn MK, Defrance M, Mendez J, Murphy N, et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J 2013; 32(5):645-655.
13. Vella P, Scelfo A, Jammula S, Chiacchiera F, Williams K, Cuomo A, et al. Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol Cell 2013; 49(4):645-656.
14. Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, Ijichi H, et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 2012; 103(4):670-676.
15. Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012; 150(6):1135-1146.
16. Yang Q, Wu K, Ji M, Jin W, He N, Shi B, et al. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients. J Biomed Nanotechnol 2013; (99):1607-1616.
17. Mercher T, Quivoron C, Couronne L, Bastard C, Vainchenker W, Bernard OA. TET2, a tumor suppressor in hematological disorders. Biochim Biophys Acta 2012; 1825(2):173-177.
18. Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013; 32(5):663-669.
19. Sun M, Song CX, Huang H, Frankenberger CA, Sankarasharma D, Gomes S, et al. HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc Natl Acad Sci U S A 2013; 110(24):9920-9925.
20. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010; 468 73(25):839-843.
21. Pronier E, Delhommeau F. Role of TET2 mutations in myeloproliferative neoplasms. Curr Hematol Malig Rep 2012; 7(1):57-64.
22. Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)q22;q23). Leukemia 2003; 17(3):637-641.
23. Kalender Atak Z, De Keersmaecker K, Gianfelici V, Geerdens E, Vandepoel R, Pauwels D, et al. High accuracy mutation detection in leukemia on a selected panel of cancer genes. PLoS One 2012; 7(6):e38463.
24. Lee SG, Cho SY, Kim MJ, Oh SH, Cho EH, Lee S, et al. Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. Haematologica 2013; 98(4):e55-7.
25. Liu C, Liu L, Chen X, Shen J, Shan J, Xu Y, et al. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1. PLoS One 2013; 8(5):e62828.
26. Ame JC, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays 2004; 26(8):882-893.
27. Burkle A. Poly(ADP-ribose). The most elaborate metabolite of NAD+. FEBS J 2005; 272(18):4576-4589.
28. Pleschke JM, Kleczkowska HE, Strohm M, Althaus FR. PolyADP-ribose. binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 2000; 275(52):40974-40980.
29. Malanga M, Althaus FR. The role of poly(ADP-ribose) in the DNA damage signaling network. Biochem Cell Biol 2005; 83(3):354-364.
30. Krishnakumar R, Kraus WL. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell 2010; 3(91):8-24.
31. Hottiger MO, Hassa PO, Luscher B, Schuler H, Koch-Nolte F. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem Sci 2010; 3(54):208-219.
32. Altmeyer M, Messner S, Hassa PO, Fey M, Hottiger MO. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites. Nucleic Acids Res 2009; 37(11):3723-3738.
33. Kraus WL, Hottiger MO. PARP-1 and gene regulation: progress and puzzles. Mol Aspects Med 2013; 34(6):1109-1123.
34. Tallis M, Morra R, Barkauskaite E, Ahel I. Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response. Chromosoma 2013.
35. Caiafa P, Guastafierro T, Zampieri M. Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns. FASEB J 2009; 2(33):672-678.
36. Thomas C, Tulin AV. Poly-ADP-ribose polymerase: Machinery for nuclear processes. Mol Aspects Med 2013; 3(46):1124-1137.
37. Krishnakumar R, Kraus WL. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 2010; 3(95):736-749.
38. Le May N, Iltis I, Ame JC, Zhovmer A, Biard D, Egly JM, et al. Poly (ADP-ribose) glycohydrolase regulates retinoic acid receptor-mediated gene expression. Mol Cell 2012; 48(5):785-798.
39. Reale A, Matteis GD, Galleazzi G, Zampieri M, Caiafa P. Modulation of DNMT1 activity by ADP-ribose polymers. Oncogene 2005; 24(1):13-19.
40. Ahel D, Horejsi Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 2009; 325(5945):1240-1243.
41. Gottschalk AJ, Trivedi RD, Conaway JW, Conaway RC. Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1.PARP1.nucleosome intermediate. J Biol Chem 2012; 287(52):43527-43532.
42. Jin SG, Kadam S, Pfeifer GP. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res 2010; 38(11):e125.
43. Kinney SM, Chin HG, Vaisvila R, Bitinaite J, Zheng Y, Esteve PO, et al. Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J Biol Chem 2011; 286(28):24685-24693.
44. Ciccarone F, Klinger FG, Catizone A, Calabrese R, Zampieri M, Bacalini MG, et al. Poly(ADP-ribosyl)ation acts in the DNA demethylation of mouse primordial germ cells also with DNA damage-independent roles. PLoS One 2012; (710):e46927.
45. Beneke S. Regulation of chromatin structure by poly(ADP-ribosyl)ation. Front Genet 2012; 3:169.
46. Guastafierro T, Catizone A, Calabrese R, Zampieri M, Martella O, Bacalini MG, et al. ADP-ribose polymer depletion leads to nuclear Ctcf re-localization and chromatin rearrangement. Biochem J 2013; 449(3):623-630.
47. Hsu CH, Peng KL, Kang ML, Chen YR, Yang YC, Tsai CH, et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep 2012; 2(3):568-579.
48. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011; 11(10):726-734.
49. Ke XS, Qu Y, Cheng Y, Li WC, Rotter V, Oyan AM, et al. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics 2010; 11:669-2164-11-669.
50. Zampieri M, Passananti C, Calabrese R, Perilli M, Corbi N, De Cave F, et al. Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity. PLoS One 2009; 4(3):e4717.
51. Zampieri M, Guastafierro T, Calabrese R, Ciccarone F, Bacalini MG, Reale A, et al. ADP-ribose polymers localized on Ctcf-Parp1-Dnmt1 complex prevent methylation of Ctcf target sites. Biochem J 2012; 441(2):645-652.
52. Nocchi L, Tomasetti M, Amati M, Neuzil J, Santarelli L, Saccucci F. Thrombomodulin is silenced in malignant mesothelioma by a poly(ADP-ribose) polymerase-1-mediated epigenetic mechanism. J Biol Chem 2011; 286(22):19478-19488.
53. Hu B, Wu Z, Hergert P, Henke CA, Bitterman PB, Phan SH. Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1. Am J Pathol 2013; 182(1):71-83.
54. Messner S, Altmeyer M, Zhao H, Pozivil A, Roschitzki B, Gehrig P, et al. PARP1 ADP-ribosylates lysine residues of the core histone tails. Nucleic Acids Res 2010; 38(19):6350-6362.
55. Guastafierro T, Cecchinelli B, Zampieri M, Reale A, Riggio G, Sthandier O, et al. CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery. J Biol Chem 2008; 283(32):21873-21880.
56. Isabelle M, Moreel X, Gagne JP, Rouleau M, Ethier C, Gagne P, et al. Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry. Proteome Sci 2010; 8:22-5956-8-22.
57. Beneke S, Meyer K, Holtz A, Huttner K, Burkle A. Chromatin composition is changed by poly(ADP-ribosyl) ation during chromatin immunoprecipitation. PLoS One 2012; 7(3):e32914.
58. Fujiki K, Shinoda A, Kano F, Sato R, Shirahige K, Murata M. PPARgamma-induced PARylation promotes local DNA demethylation by production of 5-hydroxymethylcytosine. Nat Commun 2013; 4:2262.
59. Farrar D, Rai S, Chernukhin I, Jagodic M, Ito Y, Yammine S, et al. Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl) ation. Mol Cell Biol 2010; 30(5):1199-1216.
60. Su CH, Shann YJ, Hsu MT. P53 Chromatin Epigenetic Domain Organization and P53 Transcription. Mol Cell Biol 2009; 29(1):93-103.
61. Witcher M, Emerson BM. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell 2009; 34(3):271-284.
62. Tiwari VK, Baylin SB. Breaching the boundaries that safeguard against repression. Mol Cell 2009; 34(4):395-397.